Cargando…
Interleukin-12 elicits a non-canonical response in B16 melanoma cells to enhance survival
BACKGROUND: Oncogenesis rewires signaling networks to confer a fitness advantage to malignant cells. For instance, the B16F0 melanoma cell model creates a cytokine sink for Interleukin-12 (IL-12) to deprive neighboring cells of this important anti-tumor immune signal. While a cytokine sink provides...
Autores principales: | Byrne-Hoffman, Christina N., Deng, Wentao, McGrath, Owen, Wang, Peng, Rojanasakul, Yon, J. Klinke, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249691/ https://www.ncbi.nlm.nih.gov/pubmed/32450888 http://dx.doi.org/10.1186/s12964-020-00547-4 |
Ejemplares similares
-
B16F0 melanoma exosomes deliver a unique and complex biological payload that includes Ptpn11 to suppress T lymphocyte function
por: Wu, Yueting, et al.
Publicado: (2015) -
A multiscale systems perspective on cancer, immunotherapy, and Interleukin-12
por: Klinke, David J
Publicado: (2010) -
Antitumor Activities of Interleukin-12 in Melanoma
por: Gao, Wei, et al.
Publicado: (2022) -
Enhancing the discovery and development of immunotherapies for cancer using quantitative and systems pharmacology: Interleukin-12 as a case study
por: Klinke, David J
Publicado: (2015) -
Delivery of Interleukin-15 to B16 Melanoma by Electroporation Leads to Tumor Regression and Long-term Survival
por: Marrero, Bernadette, et al.
Publicado: (2014)